News & Activities
As a young company, Amferia is growing fast and establishing ground both in Sweden and Internationally. To keep updated on our progress and activities, do check on the below posts and don’t hesitate to contact us if you would like to know more.
News & Activities
Amferia’s CTO, Saba Atefyekta is a PhD in Materials Science .
07 February 2020
Yesterday, Saba successfully defended her thesis (and work of true importance), ‘Antibacterial Surfaces for Biomedical Applications’ with a highly engaging discussion with her opponent and pioneer in the field, Professor Henk Busscher from the Netherlands.
Congratulations Doctor Atefyekta!
Amferia is happy to announce its raising of SEK 6.2 million in investment .
Almi Invest, Chalmers Ventures, along with the British investor Corithinan Properties Ltd. and Let’s Deal Founder Alexander Hars have invested a total of SEK 6.2 million in Amferia, for commercialising our wound care product that actively combats infections and kills antibiotic-resistant bacteria. Read press release here:Investment Press release_Amferia
Amferia’s Founders publish results in high impact nanotechnology journal, ACS Nano.
20 December 2019
Introducing a new class of elastomer materials! Want to know more? Check out this interesting article published in the prestigious journal ACS Nano, by our Founders Anand, Martin and colleagues from Chalmers University of Technology. https://pubs.acs.org/doi/abs/10.1021/acsnano.9b01924
Amferia at 2nd Soirée Franco-Suédoise, Paris
We had the honour to be part of the 2nd Soirée Franco-Suédoise at Palais d’Iéna organized by Chambre de Commerce Suédoise en France – CCSF and represent Amferia as one of the innovative med-tech start-up from Sweden. Big thanks to Katarina Lööf and the Chambre de Commerce Suédoise en France – CCSF for inviting Amferia and introducing us to new possibilities in France. hashtag#innovation hashtag#antibioticresistance
Photo copyright Swedish Chamber of Commerce in France and photographer Kristofer Sandberg.
November 26, 2019
Amferia had the honor to present our work at L’Oréal, Paris as part of the European Innovation Council’s corporate days. A lot of inspiring discussions and 1-1’s on synergies within the cosmetic research. Big thanks to the EU Commission, EUeic and L’Oréal for organising and hosting us. Also a big thank you to Chalmers Ventures for offering valuable support for Amferia to attend the event.
Amferia establishes R&D operations at AstraZeneca’s BioVentureHub
October 28, 2019
Amferia is very excited to move into the BioVentureHub, given the strong benefits of operating in a flourishing environment with state-of-the-art infrastructure dedicated to medtech and life science companies. We are also eager to be around so many experts within life science ranging from established to early-stage companies researching in biopharmaceuticals, medical devices and diagnostics. Amferia looks forward to be part of, learn and grow in this supportive and exciting community. Read press release here: Amferia AZ Press Release
Amferia Participates in the Annual Veterinary Hygiene Conference 2019
October 24, 2019
Our CEO, Anand Kumar Rajasekharan and Product Engineer, Edvin Blomstrand had the pleasure to recently attend the annual Veterinary Hygiene Conference in Knivsta, Stockholm. One of the primary questions of this conference was about handling antibiotic resistant infections in animal wound care – a fast growing problem in Sweden and Globally. Many interesting & enlightening discussions with expert veterinary clinicians taught us a lot about the needs and challenges in animal wound care and how Amferia might expand its innovative solutions to help veterinary healthcare. Thanks for a great conference VVHF.
Amferia wins the Start-up of the Year award at Venture Cup Sweden 2019!
The Jury's Motivation for Amferia!
“With its disruptive solution, the team has the opportunity to shake several industries as they tackle one of humanity’s greatest global threats. By addressing a world problem, millions of lives will be saved. By changing the behavior of the consumer, there is also the potential to reform the market.”
“Med sin disruptiva lösning har teamet en möjlighet att skaka om flera branscher när de tacklar ett av mänsklighetens största globala hot. Genom att angripa ett världsproblem kommer miljontals liv att kunna räddas. Genom att förändra beteende hos konsumenten finns det även potential till att reformera marknaden.”
Amferia at Brilliant Minds 2019, Stockholm
Amferia was honored to pitch as one of the ‘Next Brilliant in Tech‘ at Brilliant Minds 2019 held at Stockholm between 13-15 June. With esteemed guests like President Barack Obama, Secretary John Kerry, Greta Thunberg, the conference was a enlighetening and inspiring event with much hope for the future.
The Recent UN Report on Antibiotic Resistance
May 3, 2019
The United Nations appointed Interagency Coordination Group on Antimicrobial Resistance (IACG) has presented its report on Recommendations to Combat Antimicrobial Resistance (AMR). It is clear from the report that AMR is a global and complex threat that needs to be addressed with extreme urgency and with care. Consistent, coordinated and conscious actions are demanded, especially from the World Goverments, Academia, Public, Healthcare-Industry and Agriculture. A world where bacterial infections cannot be fought efficiently is a world of perils.
Here is an excerpt from the IACG report.
“The challenges of antimicrobial resistance are complex and multifaceted, but they are not insurmountable. Implementation of the recommendations in this report will help to save millions of lives, preserve antimicrobials for generations to come and secure the future from drug-resistant diseases.
But there is no time to wait.”
-IACG Report, April 29, 2019
Do take a minute and read the summary of this important report Englishpdf, 653kb